Business Context and Reporting Period
Company: vTv Therapeutics Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 27, 2019
Reporting Period: Fiscal year ended December 31, 2018
This filing serves as a notification that the company issued a press release announcing its financial results for the fiscal year ended December 31, 2018. The press release is attached as Exhibit 99.1 and incorporated by reference.
Key Financial Metrics
The Form 8-K text provided does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms the announcement of the fiscal year 2018 results.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. The document explicitly states that the information in the report (including the press release) shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 27, 2019) for specific financial results for the fiscal year ended December 31, 2018.
- Verify the company's status as an emerging growth company (indicated as yes in the filing).
- Confirm the exact figures for revenue, net loss, and cash position from the attached press release, as they are absent from the 8-K summary text.